NanoViricides NNVC
$ 1.31
0.0%
Quarterly report 2024-Q3
added 11-14-2024
NanoViricides Balance Sheet 2011-2024 | NNVC
Annual Balance Sheet NanoViricides
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | -12.6 M | -2.56 M | -7.08 M | -11.1 M | -15.6 M | -24.3 M | -27.7 M | -10.5 M | -14.3 M | -9.22 M |
Long Term Debt |
- | - | - | - | - | - | - | - | 3.13 M | 7.18 M | 9.04 M | 3.47 M | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | 5.47 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | 2.02 M | 6.84 M | 11.8 M | 14.7 M | 7.22 M | - | - |
Total Current Liabilities |
1.36 M | 534 K | 413 K | 351 K | 2.16 M | 2.85 M | 882 K | 4.67 M | 6.74 M | 601 K | 1.23 M | 1.18 M | 1.78 M | - |
Total Liabilities |
1.36 M | 2.03 M | 413 K | - | 2.16 M | 2.85 M | 882 K | 6.68 M | 13.6 M | 12.4 M | 16 M | 8.4 M | 1.78 M | 587 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-139 M | -131 M | -122 M | -114 M | -106 M | -92.1 M | -83.7 M | -75.1 M | -64.8 M | -54.1 M | -52.4 M | -38.3 M | -29.4 M | -23.2 M |
Total Assets |
12.8 M | 16.9 M | 23.5 M | 30.3 M | 23.9 M | 13.4 M | 18.5 M | 27 M | 36.6 M | 44.2 M | 44.6 M | 16.4 M | 15.6 M | 10.8 M |
Cash and Cash Equivalents |
4.8 M | 8.15 M | 14.1 M | 20.5 M | 13.7 M | 2.56 M | 7.08 M | 15.1 M | 24.2 M | 31.5 M | 36.7 M | 13.9 M | 14.3 M | 9.22 M |
Book Value |
11.5 M | 14.9 M | 23.1 M | 30.3 M | 21.8 M | 10.6 M | 17.7 M | 20.3 M | 23 M | 31.8 M | 28.6 M | 8.01 M | 13.9 M | 10.2 M |
Total Shareholders Equity |
11.5 M | 14.9 M | 23.1 M | 29.9 M | 21.8 M | 10.6 M | 17.7 M | 20.3 M | 23 M | 31.8 M | 23.4 M | 8.01 M | 13.9 M | 10.2 M |
All numbers in USD currency
Quarterly Balance Sheet NanoViricides
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.73 M | - | 4.73 M | - | - | - | - | - | - | - | - | - | - | - | - | 5 M | 5 M | 3.74 M | 3.6 M | 3.47 M | 3.6 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.46 M | 2.02 M | 5.84 M | 5.9 M | 7.06 M | 6.84 M | 6.84 M | 11 M | 10.6 M | 11.8 M | 11.8 M | - | 16.1 M | 20 M | 11.4 M | 14.4 M | 14.9 M | 11.3 M | 11.5 M | - | - | - | - | - | - | - | - |
Total Liabilities |
1.63 M | - | 951 K | 2.45 M | 2.03 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.68 M | - | - | 882 K | 3.19 M | 7.81 M | 6.75 M | 6.68 M | 6.68 M | 12.2 M | 14 M | 13.6 M | 13.6 M | 12.5 M | 11.6 M | 12.4 M | 12.4 M | 17.1 M | 16.8 M | 20.5 M | 12.2 M | 15.8 M | 16.8 M | 12.7 M | 13.4 M | - | 1.78 M | 1.78 M | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-143 M | -139 M | -135 M | -133 M | -131 M | -128 M | -126 M | -124 M | -122 M | -121 M | -119 M | -117 M | -114 M | -112 M | -110 M | -108 M | -106 M | -104 M | -95.6 M | -93.7 M | -92.1 M | -92.1 M | -87.8 M | -85.5 M | -83.7 M | -83.7 M | -79.9 M | -77.1 M | -75.1 M | -75.1 M | -69.4 M | -67.9 M | -64.8 M | -64.8 M | -58.2 M | -55.4 M | -54.1 M | -54.1 M | -52.9 M | -51 M | -51.9 M | 52.6 M | -46.2 M | -44.9 M | 38.3 M | - | - | - | - | - | - | - | - | - |
Total Assets |
11.7 M | 12.8 M | 13.4 M | 15.4 M | 16.9 M | 18.6 M | 20.3 M | 22.1 M | 23.5 M | 25.1 M | 26.8 M | 29.2 M | 30.3 M | 32.8 M | 28.1 M | 31.8 M | 23.9 M | 16.5 M | 11.6 M | 11.8 M | 13.4 M | 13.4 M | 15 M | 17.4 M | 18.5 M | 18.5 M | 23.7 M | 25.3 M | 27 M | 27 M | 31.4 M | 34.2 M | 36.6 M | 36.6 M | 40.8 M | 42.3 M | 44.2 M | 44.2 M | 47.6 M | 49 M | 43.9 M | 49 M | 22.9 M | 25.1 M | 16.4 M | 25.1 M | 15.6 M | 14.4 M | 15.6 M | 15.6 M | 13.6 M | 12.4 M | 10.8 M | 10.8 M |
Cash and Cash Equivalents |
3.87 M | 4.8 M | 5.25 M | 6.97 M | 8.15 M | 9.65 M | 11.4 M | 12.9 M | 14.1 M | 15.6 M | 17.3 M | 19.7 M | 20.5 M | 22.9 M | 18.4 M | 21.8 M | 13.7 M | 6.11 M | 708 K | 875 K | 2.56 M | 2.56 M | 3.9 M | 6.08 M | 7.08 M | 7.08 M | 12 M | 13.5 M | 12 M | 13.5 M | 19.3 M | 21.9 M | 19.3 M | 21.9 M | 28.2 M | 29.5 M | 28.2 M | 29.5 M | 35.3 M | 41.1 M | 35.3 M | 41.1 M | 16.9 M | 19.2 M | 16.9 M | 19.2 M | 13.9 M | 12.9 M | 13.9 M | 12.9 M | 12.1 M | 10.9 M | 12.1 M | 10.9 M |
Book Value |
10.1 M | - | 12.5 M | 13 M | 14.9 M | - | 20.3 M | 22.1 M | 23.5 M | 25.1 M | 26.8 M | 29.2 M | 30.3 M | 32.8 M | 28.1 M | 31.8 M | 23.9 M | 16.5 M | 11.6 M | 11.8 M | 13.4 M | 10.8 M | 15 M | 17.4 M | 17.7 M | 15.4 M | 15.9 M | 18.5 M | 20.3 M | 20.3 M | 19.1 M | 20.2 M | 23 M | 23 M | 28.4 M | 30.7 M | 31.8 M | 31.8 M | 30.5 M | 32.2 M | 23.4 M | 36.8 M | 7.1 M | 8.31 M | 3.73 M | 11.8 M | 15.6 M | 12.6 M | 13.9 M | 15.6 M | 13.6 M | 12.4 M | 10.8 M | 10.8 M |
Total Shareholders Equity |
10.1 M | 11.5 M | 12.5 M | 13 M | 14.9 M | 18.2 M | 19.9 M | 21.6 M | 23.1 M | 24.8 M | 26.5 M | 28.3 M | 29.9 M | 31.9 M | 27.7 M | 27.7 M | 27.7 M | 30 M | 7.72 M | 7.72 M | 7.72 M | 9.13 M | 13.8 M | 13.8 M | 13.8 M | 16 M | 15.9 M | 18.5 M | 15.9 M | 18.5 M | 19.1 M | 20.2 M | 23 M | 23 M | 28.4 M | 30.7 M | 31.8 M | 31.8 M | 30.5 M | 32.2 M | 23.4 M | 36.8 M | 7.1 M | 8.31 M | 10.2 M | 11.8 M | 14.2 M | 12.8 M | 13.9 M | 12.8 M | 12.4 M | 11.4 M | 10.2 M | 10.2 M |
All numbers in USD currency